Clear Harbor Asset Management’s AstraZeneca AZN Stock Holding History

Clear Harbor Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,013	Closed	-$271K	–	377
2023 Q4	$271K	Buy	2,013 +288	+17%	+$37.4K	0.02%	292
2023 Q3	$234K	Sell	1,725 -25	-1%	-$3.42K	0.02%	295
2023 Q2	$250K	Buy	+1,750	New	+$257K	0.02%	287
2020 Q4	–	Sell	-250	Closed	-$27.4K	–	346
2020 Q3	$27.4K	Buy	+250	New	+$27.8K	﹤0.01%	464
2020 Q1	–	Sell	-250	Closed	-$24.9K	–	313
2019 Q4	$24.9K	Buy	+250	New	+$23.5K	﹤0.01%	492

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clear Harbor Asset Management's AZN Position: Q1 2024 in Review

Clear Harbor Asset Management sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 2,013 shares — an estimated $271K sold.

Clear Harbor Asset Management first reported a position in AZN in Q4 2019 and held it in 5 quarters. The position peaked at $271K in Q4 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

Clear Harbor Asset Management reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
Clear Harbor Asset Management sold 2,013 AstraZeneca shares in Q1 2024, an estimated $271K.
Clear Harbor Asset Management first reported a position in AstraZeneca in Q4 2019 and held it in 5 quarters.
Clear Harbor Asset Management's AstraZeneca position peaked at $271K in Q4 2023.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Clear Harbor Asset Management's 13F filing for Q1 2024, filed 10 May 2024.